Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
29
PharmaCompass offers a list of Glucarpidase API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glucarpidase manufacturer or Glucarpidase supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glucarpidase manufacturer or Glucarpidase supplier.
PharmaCompass also assists you with knowing the Glucarpidase API Price utilized in the formulation of products. Glucarpidase API Price is not always fixed or binding as the Glucarpidase Price is obtained through a variety of data sources. The Glucarpidase Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Glucarpidase manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glucarpidase, including repackagers and relabelers. The FDA regulates Glucarpidase manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glucarpidase API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Glucarpidase supplier is an individual or a company that provides Glucarpidase active pharmaceutical ingredient (API) or Glucarpidase finished formulations upon request. The Glucarpidase suppliers may include Glucarpidase API manufacturers, exporters, distributors and traders.
click here to find a list of Glucarpidase suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Glucarpidase CEP of the European Pharmacopoeia monograph is often referred to as a Glucarpidase Certificate of Suitability (COS). The purpose of a Glucarpidase CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Glucarpidase EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Glucarpidase to their clients by showing that a Glucarpidase CEP has been issued for it. The manufacturer submits a Glucarpidase CEP (COS) as part of the market authorization procedure, and it takes on the role of a Glucarpidase CEP holder for the record. Additionally, the data presented in the Glucarpidase CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Glucarpidase DMF.
A Glucarpidase CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Glucarpidase CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Glucarpidase suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Glucarpidase as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Glucarpidase API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Glucarpidase as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Glucarpidase and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Glucarpidase NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Glucarpidase suppliers with NDC on PharmaCompass.
Glucarpidase Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glucarpidase GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glucarpidase GMP manufacturer or Glucarpidase GMP API supplier for your needs.
A Glucarpidase CoA (Certificate of Analysis) is a formal document that attests to Glucarpidase's compliance with Glucarpidase specifications and serves as a tool for batch-level quality control.
Glucarpidase CoA mostly includes findings from lab analyses of a specific batch. For each Glucarpidase CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glucarpidase may be tested according to a variety of international standards, such as European Pharmacopoeia (Glucarpidase EP), Glucarpidase JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glucarpidase USP).
